DongKoo Bio & Pharma Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	21,561	25,372	15,713	12,514	19,557
Short-Term Investments	1,107	506.9	1,941	1,351	143.14
Trading Asset Securities	12,497	10,371	5,245	21,271	12,399
Cash & Short-Term Investments	35,165	36,250	22,898	35,136	32,100
Cash Growth	-3.00%	58.31%	-34.83%	9.46%	8.50%
Accounts Receivable	19,343	19,876	19,879	18,503	15,774
Other Receivables	253.08	1,352	1,570	898.47	633.49
Receivables	21,370	23,953	22,449	19,402	16,408
Inventory	49,996	45,962	42,606	31,428	24,964
Prepaid Expenses	450.63	324.71	216.61	225.89	229.66
Other Current Assets	19,320	751.62	195.02	1,226	131.5
Total Current Assets	126,301	107,242	88,365	87,417	73,832
Property, Plant & Equipment	77,445	66,222	50,483	39,681	40,051
Long-Term Investments	121,476	50,419	39,800	33,619	35,498
Other Intangible Assets	5,386	5,467	10,903	9,010	3,048
Long-Term Deferred Tax Assets	-	3,162	291.5	6.95	-
Long-Term Deferred Charges	2,937	7,705	-	-	-
Other Long-Term Assets	2,805	3,843	1,260	2,325	2,358
Total Assets	336,350	244,061	191,103	172,059	154,786
Accounts Payable	5,291	15,591	11,202	14,300	11,591
Accrued Expenses	9,920	11,337	10,274	9,637	6,496
Short-Term Debt	105,156	74,876	40,500	33,000	18,070
Current Portion of Long-Term Debt	-	-	-	-	5,000
Current Portion of Leases	639.78	681.03	842.63	567.83	453.23
Current Income Taxes Payable	390.96	3,325	1,638	2,576	1,978
Other Current Liabilities	16,076	9,441	8,863	5,963	6,434
Total Current Liabilities	137,473	115,251	73,318	66,044	50,022
Long-Term Debt	22,852	10,467	1,447	-	-
Long-Term Leases	134.07	616.95	1,014	754.22	770.27
Pension & Post-Retirement Benefits	0	0	277.09	0	205.81
Long-Term Deferred Tax Liabilities	6,777	8.89	4.5	140.93	2,315
Other Long-Term Liabilities	16,954	12,269	4,596	3,015	1,350
Total Liabilities	184,190	138,613	80,658	69,953	54,662
Common Stock	14,232	14,232	14,232	14,232	14,232
Additional Paid-In Capital	33,555	33,063	33,063	33,063	33,063
Retained Earnings	114,061	67,320	69,735	61,675	57,158
Treasury Stock	-10,545	-10,545	-7,137	-7,058	-4,062
Comprehensive Income & Other	398.21	1,261	507.18	193.39	-266.18
Total Common Equity	151,702	105,332	110,400	102,106	100,124
Minority Interest	456.9	116.03	44.92	-	-
Shareholders' Equity	152,159	105,448	110,445	102,106	100,124
Total Liabilities & Equity	336,350	244,061	191,103	172,059	154,786
Total Debt	128,782	86,641	43,804	34,322	24,294
Net Cash (Debt)	-93,617	-50,391	-20,906	813.88	7,806
Net Cash Growth	-	-	-	-89.57%	33.61%
Net Cash Per Share	-3335.20	-1856.67	-756.89	29.32	276.23
Filing Date Shares Outstanding	27.04	27.04	27.61	27.62	28.04
Total Common Shares Outstanding	27.04	27.04	27.61	27.62	28.04
Working Capital	-11,173	-8,009	15,046	21,374	23,811
Book Value Per Share	5609.35	3895.10	3998.84	3696.33	3570.78
Tangible Book Value	146,317	99,865	99,497	93,096	97,076
Tangible Book Value Per Share	5410.21	3692.93	3603.92	3370.16	3462.08
Land	13,262	13,262	10,849	10,849	10,584
Buildings	28,815	27,613	29,667	27,353	26,899
Machinery	9,520	12,456	19,768	17,741	17,813
Construction In Progress	21,283	7,823	10,694	1,451	887.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.